Glioblastoma Multiforme Treatment’s Long Process and Average Affectivity Is Concerning Medical Professionals across the Globe to Develop New Techniques
Treatments of glioblastoma multiforme has become one of the main concerns for medical professionals around the world mainly in nations such as the U.S., U.K., Italy, and Singapore. Glioblastoma multiforme is a rare type of cancer that has grown from one cell to form many different types of tumors (such as those in situ, epidermis, dermal, and bone). The cells of this cancer are very unusual, and it forms new blood vessels in the affected areas once it multiplies. Glioblastoma multiforme may also accumulate necrotic tissue at its core, resulting in a condition called capillary fragility.
This
disease develops in both children and adults, but it typically affects children
more than adults. Children can develop either single tumors or in groups of two
or more. Children can also experience glioblastoma multiforme when they suffer
from another condition or from issues that happened during birth. For example,
individuals with cystic fibrosis can also suffer from the condition, as can
people with multiple cysts on the ovaries.
A
major issue with treating glioblastoma multiforme is difficulty in proper diagnosis.
For instance, the symptoms, include weight loss, appetite loss, fever,
polydipsia (difficulties with concentration), anemia, photophobia (dislike of
bright lights), and abdominal pain. These symptoms can be attributed to several
different problems within the body. Since the exact nature of each symptom can
vary, it's important to have a medical professional to check the patient's
medical history.
Unfortunately,
this disease does not have a cure currently. However, there are ways to treat
some of the symptoms associated with glioblastoma multiforme, such as reducing
the tumors or removing them entirely. In many cases, simply monitoring the
patient's health and making lifestyle changes can help control some of these
problems.
Recently,
many people across the globe are suffering from glioblastoma multiforme. According
to the MS Anderson Cancer Center, every year around 12,000 people in the U.S.
get diagnosed with this disease. Currently, chemotherapy along with the drug
Temozolomide, which is manufactured by Integrated DNA Technologies (IDT) and
launched in the US market, is the most recent treatment technique used for
patients with Glioblastoma Multiforme. During radiation therapy, Temozolomide
is given to the patient every day, after that it is given in 6-12 cycles after
radiation therapy. Each cycle lasts for approximately 28 days with the drug
given on the first day of a cycle.
Comments
Post a Comment